SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-17-052789
Filing Date
2017-08-21
Accepted
2017-08-21 07:09:05
Documents
6
Period of Report
2017-08-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a17-20734_18k.htm 8-K 40205
2 EX-10.1 a17-20734_1ex10d1.htm EX-10.1 2162734
3 EX-10.2 a17-20734_1ex10d2.htm EX-10.2 17252
4 EX-10.3 a17-20734_1ex10d3.htm EX-10.3 55050
5 EX-99.1 a17-20734_1ex99d1.htm EX-99.1 12302
6 GRAPHIC g207341mmi001.jpg GRAPHIC 2107
  Complete submission text file 0001104659-17-052789.txt   2292147
Mailing Address 2000 SIERRA POINT PARKWAY SUITE 500 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY SUITE 500 BRISBANE CA 94005 6502389600
Innoviva, Inc. (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30319 | Film No.: 171042119
SIC: 2834 Pharmaceutical Preparations